In a filing, Rocket Pharmaceuticals Inc revealed its insider Militello John unloaded Company’s shares for reported $15978.0 on Nov 21 ’24. In the deal valued at $13.05 per share,1,224 shares were sold. As a result of this transaction, Militello John now holds 49,310 shares worth roughly $0.68 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Patel Kinnari sold 4,588 shares, generating $59,892 in total proceeds. Upon selling the shares at $13.05, the insider now owns 392,395 shares.
Before that, Shah Gaurav sold 11,091 shares. Rocket Pharmaceuticals Inc shares valued at $144,782 were divested by the CEO at a price of $13.05 per share. As a result of the transaction, Shah Gaurav now holds 707,328 shares, worth roughly $9.82 million.
Scotiabank initiated its Rocket Pharmaceuticals Inc [RCKT] rating to a Sector outperform in a research note published recently. A number of analysts have revised their coverage, including Goldman’s analysts, who began to cover the stock in early April with a ‘”a Neutral”‘ rating. Cantor Fitzgerald began covering RCKT with “an Overweight” recommendation on October 24, 2023. Morgan Stanley started covering the stock on February 01, 2023. It rated RCKT as “an Overweight”.
Price Performance Review of RCKT
On Friday, Rocket Pharmaceuticals Inc [NASDAQ:RCKT] saw its stock jump 4.28% to $13.89. Over the last five days, the stock has lost -3.47%. Rocket Pharmaceuticals Inc shares have fallen nearly -53.65% since the year began. Nevertheless, the stocks have fallen -46.23% over the past one year. While a 52-week high of $32.53 was reached on 02/27/24, a 52-week low of $12.62 was recorded on 11/20/24. SMA at 50 days reached $16.10, while 200 days put it at $21.12.
Levels Of Support And Resistance For RCKT Stock
The 24-hour chart illustrates a support level at 13.43, which if violated will result in even more drops to 12.96. On the upside, there is a resistance level at 14.26. A further resistance level may holdings at 14.62. The Relative Strength Index (RSI) on the 14-day chart is 40.46, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.14, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 46.86%. Stochastics %K at 37.09% indicates the stock is a holding.
How much short interest is there in Rocket Pharmaceuticals Inc?
A steep rise in short interest was recorded in Rocket Pharmaceuticals Inc stocks on 2024-11-15, dropping by -0.42 million shares to a total of 11.09 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 11.52 million shares. There was a decline of -3.82%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on November 08, 2022 when Canaccord Genuity began covering the stock and recommended ‘”a Buy”‘ rating along with a $53 price target.
